Company Profiles

driven by the PitchBook Platform

Anexon

Description

Developer of therapeutics for cardiovascular disease. The company is focused on developing an alternatively spliced variant of brain natriuretic peptide, ANX-042, for the treatment of patients with chronic heart failure and kidney dysfunction.

2006

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

$1M

Latest Deal Amount

$8.5M

Total Amount Raised

Description

Developer of therapeutics for cardiovascular disease. The company is focused on developing an alternatively spliced variant of brain natriuretic peptide, ANX-042, for the treatment of patients with chronic heart failure and kidney dysfunction.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Other Healthcare

Primary Office

55 Cambridge Parkway Suite 301 Cambridge, MA 02142United States +1 (617) 252-4343
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Anexon's full profile, request a free trial.

    Anexon Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Anexon Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Anexon Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    HealthCare VenturesVenture CapitalMinority000 0000000 0000
    Mayo Clinic VenturesCorporate Venture CapitalMinority000 0000000 0000
    HealthCare Ventures Venture Capital
    Mayo Clinic Ventures Corporate Venture Capital

    Anexon Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Christopher Mirabelli Ph.DDirector, President & Chief Executive Officer
    Christopher Mirabelli Ph.D Director, President & Chief Executive Officer
    Request full access to PitchBook